Biotech solutions

Anomaly Detection for Biotech

For biotech research labs considering anomaly detection, the question is rarely "can it be done" — it's "can it be done in a way the business will actually adopt." That's where Beryl Analytics comes in.

Book a free analytics audit →

Why biotech teams choose Beryl Analytics for anomaly detection

How we deliver anomaly detection engagements

  1. 01

    Frame the decision

    Before we touch a model, we agree what decision the output will change, who owns that decision, and what counts as success in dollars or risk reduced.

  2. 02

    Land a working slice

    A narrow but complete production system: source-to-decision in 4-6 weeks, monitored, owned, and measurable. Then we expand from real evidence.

  3. 03

    Embed the operating model

    Retraining cadence, alerting thresholds, escalation runbooks, and clear ownership. The system stops being "the analytics project" and becomes part of how the business runs.

  4. 04

    Compound the wins

    Reuse the foundation across the next use case. Each engagement makes the next cheaper, faster, and lower-risk.

Frequently asked questions about Anomaly Detection for Biotech

How long does a typical Anomaly Detection engagement take for a biotech business?

Most anomaly detection projects for biotech research labs land a working production slice within 4-6 weeks, then harden and expand over the following 8-12 weeks. Larger biotech programmes that touch multiple business units take 4-6 months end-to-end.

What data do you need to start a Anomaly Detection project in biotech?

Minimum viable inputs are 12-18 months of historical transactional or operational data, basic entity reference tables, and access to the systems that will consume the output. We can work with messy data — cleaning is part of the engagement.

Can Beryl Analytics integrate anomaly detection with our existing biotech research labs systems?

Yes. We're tool-agnostic and have integrated with Snowflake, BigQuery, Databricks, Salesforce, SAP, Oracle, custom in-house platforms, and dozens of biotech-specific systems. Insights surface inside the tools your operators already use.

How do you measure success on a Anomaly Detection engagement?

Before we model anything, we agree the business decision the output will change and the dollar metric we're targeting — revenue lifted, cost avoided, or risk reduced. Anomaly Detection engagements in biotech typically return 4-12x within the first year.

Do you work with biotech businesses outside major NZ and AU cities?

Yes. We deliver remotely across New Zealand and Australia and visit on-site for discovery, key workshops, and go-live. Distance is not a blocker — many of our highest-impact anomaly detection engagements have been with regional biotech research labs.

Related Biotech solutions

Anomaly Detection in other industries

Ready to put anomaly detection to work in your biotech business?

Get a free analytics audit →